MOBERG | Boston Medical Center
BMC Updates and Information.

BMC is seeing patients at our hospital and clinics—see how we’re keeping everyone safe. Book your next appointment today or learn about our telehealth options.

To protect the health of patients and staff, BMC is restricting all visitors unless pre-approved by each patient's care team under extenuating circumstances.

Community vaccine sites are now open for booking appointments for Boston residents

doctor Find a doctor


MOBERG: Outcome Prognostication in Traumatic Brain Injury using MOBERG CNS-100

Supported by: Department

Principal Investigator at BMC: Courtney Takahashi, MD

Primary Research ContactBrandon Finn, BA (617-638-8650)



The MOBERG study is a sub-study of the OPTIMISM collaborative study between the University of Massachusetts (UMASS) Medical School and Boston Medical Center. In this study, we will follow patients with moderate to severe traumatic brain injury (TBI), which is defined as a loss of consciousness after traumatic brain injury for more than 30 minutes. These patients will be followed for the first 72 hours after TBI by using the MOBERG CNS-100 device, which will be connected to bedside monitors to continuously collect data.

The rationale behind this study is that there is not much known about what is happening during the first 72 hours after TBI, so this study is designed to collect all possible information monitored to analyze what exactly is changing during this acute phase.


Enrollment Criteria

Inclusion Criteria:

  1. Age 18 years and older
  2. Moderate to severe traumatic brain injury diagnosed on admission, defined as a loss of consciousness after TBI for more than 30 minutes
  3. Enrolled within 24 hours of admission

Exclusion Criteria:

  1. Traumatic brain injury that is not diagnosed as moderate to severe, defined as a loss of consciousness after TBI for less than 30 minutes

Status: Actively enrolling patients